Softbank Group Corp Eq Rx, Inc. Transaction History

Softbank Group Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $9.15 Million - $11.1 Million	-5,683,387 Reduced 26.17%	16,034,970 $29.8 Million
Q1 2023 May 15, 2023	SELL	$1.8 - $2.83 $30.4 Million - $47.8 Million	-16,895,579 Reduced 43.76%	21,718,357 $42.1 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $9.35 Million - $25.1 Million	-4,562,664 Reduced 10.57%	38,613,936 $95 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $138 Million - $246 Million	43,176,600 New	43,176,600 $202 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Softbank Group Corp, based on Form 13F filings with the SEC.

Stay updated on Softbank Group Corp with notifications on news.